The Set-Point Study: Evaluating Effects of Changing Glucose Target on Bionic Pancreas Performance
NCT02509065
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
24
Enrollment
OTHER
Sponsor class
Conditions
Type 1 Diabetes
Type 2 Diabetes
Interventions
DEVICE:
Bionic Pancreas
OTHER:
Usual Care
Sponsor
Massachusetts General Hospital